Top Construction Material Stocks To Watch Right Now

Related CTSH Cognizant Technology Solutions Elects Jonathan Chadwick As Director Earnings Recap For February 8 Related CI A Quick-And-Easy Guide To All The Calls At Ira Sohn 2016 The 10 Least Likely M&A Deals To Go Through

Cognizant Technology Solutions Corp (NASDAQ: CTSH) is estimated to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion.

CIGNA Corporation (NYSE: CI) is projected to report its quarterly earnings at $2.15 per share on revenue of $10.00 billion.

Top Construction Material Stocks To Watch Right Now: National Grid Transco, PLC(NGG)

National Grid plc, incorporated on July 11, 2000, is an electricity and gas utility company focused on transmission and distribution activities in electricity and gas in both the United Kingdom and the United States. The Company’s segments include UK Electricity Transmission, which is engaged in high voltage electricity transmission networks in Great Britain; UK Gas Transmission, which is the gas transmission network in Great Britain and UK liquefied natural gas (LNG) storage activities; UK Gas Distribution, which includes approximately four of the eight regional networks of Great Britain’s gas distribution system, and US Regulated, which includes gas distribution networks, electricity distribution networks and high voltage electricity transmission networks in New York, and New England and electricity generation facilities in New York. Its other activities relate to non-regulated businesses and other commercial operations not included within the above segments, including t he United Kingdom gas metering activities; the Great Britain-France Interconnector; the United Kingdom property management; a United Kingdom LNG import terminal (National Grid Grain LNG Limited); the United States LNG operations; the United States unregulated transmission pipelines; together with corporate activities.

UK Electricity Transmission

The Company owns and operates the electricity transmission network in England and Wales, with day-to-day responsibility for balancing supply and demand. The Company operates but do not own the Scottish networks. Its networks comprise approximately 7,200 kilometers (over 4,470 miles) of overhead line, approximately 1,500 kilometers (over 930 miles) of underground cable and approximately 340 substations.

UK Gas Transmission

The Company owns and operates the gas national transmission system in Great Britain, with day-to-day responsibility for balancing supply and demand. Its network co mprises approximately 7,660 kilometers (over 4,760 miles) of! high pressure pipe and approximately 20 compressor stations. The gas throughput across the system is over 80 billion cubic meters.

UK Gas Distribution

The Company owns and operates approximately four gas distribution networks comprising over 131,000 kilometers (over 81,400 miles) of pipeline. The Company transports gas from the national transmission system to approximately 10.9 million consumers on behalf of approximately 40 shippers.

US Regulated

The Company jointly owns and operates transmission facilities across upstate New York, Massachusetts, New Hampshire, Rhode Island and Vermont. It owns and operates electricity distribution networks in upstate New York, Massachusetts and Rhode Island. The assets it operates include over 170 kilometers (approximately 110 miles) of underground cable, over 490 transmission substations and approximately 690 distribution substations. It owns and operates gas distribution networks acros s the northeastern United States, located in upstate New York, New York City, Long Island, Massachusetts and Rhode Island. The Company forecasts, plans for and procures over 20 billion standard cubic meters of gas each year.

Advisors’ Opinion:

  • [By Paul R. La Monica]

    And the infrastructure fund has stakes in cell phone tower owners Crown Castle (CCI) and SBA Communications (SBAC), as well as giant British gas and electric utility National Grid (NGG).

Top Construction Material Stocks To Watch Right Now: Panera Bread Company(PNRA)

Panera Bread Company, together with its subsidiaries, owns, operates, and franchises retail bakery-cafes in the United States and Canada. Its bakery-cafes offer fresh baked goods, sandwiches, soups, salads, custom roasted coffees, and other complementary products, as well as provide catering services. The company also manufactures and supplies dough and other products to company-owned and franchise-operated bakery-cafes. As of March 29, 2011, it owned and franchised 1,467 bakery-cafes under the Panera Bread, Saint Louis Bread Co., and Paradise Bakery & Cafe names. The company was founded in 1981 and is based in St. Louis, Missouri.

Advisors’ Opinion:

  • [By Ben Levisohn]

    We are lowering our price target to $285, from $300, as we believe that the Street still needs to adjust longer-term earnings growth expectations…We still recommend that investors seeking upside in the fast casual segment accumulate shares of Zoes Kitchen (ZOES) and Panera Bread (PNRA), as both names appear to be gaining incremental market share at the expense of Chipotle Mexican Grill.

  • [By Benzinga News Desk]

    Oppenheimer downgraded Verizon (NYSE: VZ) to Perform.
    Stifel downgraded Disney (NYSE: DIS) to Hold.
    Argus upgraded Johnson & Johnson (NYSE: JNJ) to Buy.
    Canaccord upgraded Diamondback Energy (NASDAQ: FANG) to Buy.
    RBC initiated coverage on Panera Bread (NASDAQ: PNRA) at Outperform.
    Argus started Charter (NASDAQ: CHTR) at Buy.

Top 10 Value Companies To Watch In Right Now: Medivation Inc.(MDVN)

Medivation, Inc., a biopharmaceutical company, focuses on the development of small molecule drugs for the treatment of castration-resistant prostate cancer, Alzheimer?s disease, and Huntington disease. The company?s product candidates under clinical development include MDV3100, which is in Phase 3 development for the treatment of castration-resistant prostate cancer; and dimebon, which is in Phase 3 clinical trial for the treatment of Alzheimer?s disease and Huntington disease. It has collaboration agreements with Pfizer Inc. to develop and commercialize dimebon; and Astellas Pharma Inc. to develop and commercialize MDV3100. The company was founded in 2003 and is based in San Francisco, California.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process forMedivation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation’s board. Of the three biotech giants, Citigroup’s Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why: